TRAW
$2.20
Market ClosedAs of Mar 17, 8:00 PM UTC
Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small-molecule oral product candidates for respiratory viral diseases and cancer.
Recent News
No recent news found.
$2.20
Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small-molecule oral product candidates for respiratory viral diseases and cancer.